FR2294706B1 - - Google Patents

Info

Publication number
FR2294706B1
FR2294706B1 FR7539174A FR7539174A FR2294706B1 FR 2294706 B1 FR2294706 B1 FR 2294706B1 FR 7539174 A FR7539174 A FR 7539174A FR 7539174 A FR7539174 A FR 7539174A FR 2294706 B1 FR2294706 B1 FR 2294706B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7539174A
Other versions
FR2294706A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of FR2294706A1 publication Critical patent/FR2294706A1/fr
Application granted granted Critical
Publication of FR2294706B1 publication Critical patent/FR2294706B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7539174A 1974-12-21 1975-12-19 Nouveaux derives de la xanthine, leur procede de preparation et leur utilisation Granted FR2294706A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (2)

Publication Number Publication Date
FR2294706A1 FR2294706A1 (fr) 1976-07-16
FR2294706B1 true FR2294706B1 (fr) 1978-12-01

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7539174A Granted FR2294706A1 (fr) 1974-12-21 1975-12-19 Nouveaux derives de la xanthine, leur procede de preparation et leur utilisation

Country Status (31)

Country Link
US (1) US3998953A (fr)
JP (1) JPS5188995A (fr)
AT (1) AT341540B (fr)
AU (1) AU501889B2 (fr)
BE (1) BE836898A (fr)
BG (1) BG25518A3 (fr)
CA (1) CA1036159A (fr)
CH (1) CH628346A5 (fr)
CS (1) CS191289B2 (fr)
DD (1) DD124984A5 (fr)
DE (1) DE2460929A1 (fr)
DK (1) DK137677C (fr)
ES (2) ES443738A1 (fr)
FI (1) FI62089C (fr)
FR (1) FR2294706A1 (fr)
GB (1) GB1517710A (fr)
GR (1) GR59204B (fr)
HU (1) HU174673B (fr)
IE (1) IE43208B1 (fr)
IL (1) IL48697A (fr)
LU (1) LU73972A1 (fr)
NL (1) NL7514837A (fr)
NO (1) NO144928C (fr)
NZ (1) NZ179599A (fr)
PH (1) PH11810A (fr)
PL (1) PL99165B1 (fr)
RO (1) RO68381A (fr)
SE (1) SE420493B (fr)
SU (1) SU603340A3 (fr)
YU (1) YU39004B (fr)
ZA (1) ZA757865B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (fr) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
FI62089B (fi) 1982-07-30
FI62089C (fi) 1982-11-10
JPS5188995A (fr) 1976-08-04
IE43208B1 (en) 1981-01-14
ATA904575A (de) 1977-06-15
IL48697A0 (en) 1976-02-29
NO754317L (fr) 1976-06-22
RO68381A (fr) 1982-02-26
YU39004B (en) 1983-12-31
NZ179599A (en) 1978-03-06
YU323475A (en) 1982-08-31
DK137677C (da) 1978-09-25
ZA757865B (en) 1977-08-31
FI753543A (fr) 1976-06-22
NO144928C (no) 1981-12-09
FR2294706A1 (fr) 1976-07-16
AU8754775A (en) 1977-06-23
SU603340A3 (ru) 1978-04-15
GR59204B (en) 1977-11-26
CA1036159A (fr) 1978-08-08
IE43208L (en) 1976-06-21
GB1517710A (en) 1978-07-12
PH11810A (en) 1978-07-10
IL48697A (en) 1979-07-25
ES443738A1 (es) 1977-04-16
BG25518A3 (en) 1978-10-10
NL7514837A (nl) 1976-06-23
DK137677B (da) 1978-04-17
DD124984A5 (fr) 1977-03-23
BE836898A (fr) 1976-06-21
HU174673B (hu) 1980-03-28
AU501889B2 (en) 1979-07-05
US3998953A (en) 1976-12-21
CH628346A5 (de) 1982-02-26
DK571875A (da) 1976-06-22
PL99165B1 (pl) 1978-06-30
SE420493B (sv) 1981-10-12
DE2460929C2 (fr) 1987-12-17
CS191289B2 (en) 1979-06-29
LU73972A1 (fr) 1977-02-15
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
DE2460929A1 (de) 1976-06-24
SE7514477L (sv) 1976-06-22

Similar Documents

Publication Publication Date Title
AU495920B2 (fr)
AU7138274A (fr)
AU7099174A (fr)
BG20443A1 (fr)
BG22484A1 (fr)
AU481082A (fr)
AU481101A (fr)
AU481340A (fr)
AU481457A (fr)
AU481580A (fr)
AU482019A (fr)
AU482110A (fr)
AU482332A (fr)
AU480580A (fr)
AU480469A (fr)
DD110327A1 (fr)
BG19607A1 (fr)
BG19772A1 (fr)
BG19828A1 (fr)
BG19873A1 (fr)
BG19954A1 (fr)
BG19982A1 (fr)
BG20001A1 (fr)
BG20159A1 (fr)
LU73972A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse